Digital therapeutics innovation centre part of R&D firm’s life sciences expansion

Engineering and R&D services firm Altran, has expanded its Life Sciences business in the Americas, combining assets and capabilities from several acquisitions to offer new end-to-end solutions.

The company hopes it will help clients bring life-saving products and digital innovations to market more quickly.

Altran has also increased investments in patient-centric innovations and is will be opening a Digital Therapeutics Innovation Centre in Burlington, Massachusetts, just outside of Boston, this autumn. It will serve Altran’s clients in the pharmaceutical, biotechnology, medical device and hospital and health services industries across the Americas.

Laila Worrell, CEO of Altran North America, said: “Our investment and expansion of our Americas Life Sciences business will allow our life sciences clients to accelerate innovation and product development, reducing time to market and improving quality of life and longevity for millions of patients. We have a network of 2,800 industry experts in 15 countries – engineers, pharmacists, medical doctors, regulatory specialists – and a 35-year heritage of serving the world’s leading healthcare, pharmaceutical and medical technology companies. We are uniquely positioned to partner with clients globally to deliver highly customised, leading-edge solutions.”

Altran offers patient-centric product development and digital healthcare services aimed to enhance patient engagement and medical outcomes while improving clients’ operational performance. Leveraging its industry experience and cross-industry technology capabilities, Altran Life Sciences business in the Americas provides services in three main areas:

  • Patient-centric product development, using human-centric design, system engineering, mechanical engineering, software frameworks, wireless communications and testing to develop new digital therapeutics and connected health solutions (including cybersecurity)
  • Life sciences digitalisation, providing digital health, big data analytics and Internet of Things (IoT) solutions and services to help companies transform their businesses and organisations, and generate value from data
  • Industrial performance and regulatory compliance, harnessing expertise in quality assurance, process engineering and digital manufacturing to optimise performance, compliance and managed services.


'Digital therapeutics innovation centre part of R&D firm’s life sciences expansion' has no comments

Be the first to comment this post!

Would you like to share your thoughts?

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

© 2019 Rapid Life Sciences Ltd, a Rapid News Group Company. All Rights Reserved.

Privacy policy

Terms and conditions